
Key Benefits
Identified in ResearchPromotes Synaptogenesis: It stimulates the physical creation of new brain synapses and dendritic spines. This builds a denser network for cellular communication.
Improves Learning and Memory: Animal testing indicates it aids in memory consolidation, acquisition, and retrieval. It has successfully reversed cognitive deficits in damaged rat models.
Potent Neuroregeneration: In lab assays, it exhibits neurotrophic activity. It performs seven orders of magnitude more potently than Brain-Derived Neurotrophic Factor (BDNF).
Crosses the Blood-Brain Barrier: Its specific chemical structure allows it to effectively pass from the bloodstream into the central nervous system. This gives it high biological availability.
Crosses the Blood-Brain Barrier: Its specific chemical structure allows it to effectively pass from the bloodstream into the central nervous system. This gives it high biological availability.
Fights Neuroinflammation: Studies indicate it helps lower pro-inflammatory cytokines like IL-1β and TNF-α. Simultaneously, it boosts anti-inflammatory markers like IL-10.
How It Works
Unlike traditional brain stimulants that briefly manipulate neurotransmitter amounts, Dihexa acts as a HGF (Hepatocyte Growth Factor) mimetic. According to scientific reports from groups like the Alzheimer’s Drug Discovery Foundation, it binds with high affinity to c-Met receptors on neurons. This action kicks off a cascade of signaling pathways that repair neural tissue, prompt cell division, and establish structural updates to your neural architecture.

Dermorphin is a natural, highly potent opioid peptide found in frog skin that provides extreme pain relief, high receptor selectivity, and long-lasting tissue stability. It acts as a powerful mu-opioid receptor agonist with significantly greater potency than morphine.
Key Therapeutic BenefitsIntense Analgesia: Shows dozens to thousands of times higher potency than morphine in animal and tissue models, effectively blocking severe nociceptive and neuropathic pain signals.
High Receptor Selectivity: Binds strongly and specifically to mu-opioid receptors with minimal affinity for delta or kappa receptors, which theoretically creates a cleaner target profile than standard non-selective opiates.
Enzymatic Stability: Features a unique D-amino acid (D-alanine) in its sequence that protects the molecule from rapid degradation by bodily peptidases, allowing for longer-lasting activity.

Chonluten (also known as Tripeptide T-34 or EDG) is a synthetic short peptide bioregulator consisting of three amino acids in the sequence L-Glutamic acid, L-Aspartic acid, and L-Glycine. Developed as part of the Khavinson peptide framework, it is primarily researched and marketed for its targeted biological activity on the respiratory system and gastrointestinal mucosa.
Primary Characteristics & Research FocusTissue Specificity: It acts as an organ-specific cytogenetic regulator, primarily targeting lung tissues, bronchial mucosa, and respiratory epithelium.
Mechanism of Action: Research from platforms like PubMed indicates that Chonluten interacts with cellular mechanisms to modulate gene expression, protein biosynthesis, and oxidative stress responses.
Anti-Inflammatory Properties: In vitro laboratory research suggests it assists in inhibiting pro-inflammatory cytokine production (such as TNF-α and IL-6), promoting cellular regeneration over tissue degradation.
Investigational Uses: Because it stabilizes mucosal integrity, it is evaluated in experimental frameworks for potential support in chronic conditions like COPD, asthma, and gastritis.

Cardiogen (sequence: Ala-Glu-Asp-Arg or AEDR) is a synthetic short-chain peptide bioregulator that primarily targets cardiovascular health and tissue repair. Preclinical research indicates that it acts at a cellular level to optimize heart function and promote cellular regeneration.
Cardiac Repair and Muscle ProliferationCardiomyocyte Growth: It stimulates the proliferation and survival of cardiomyocytes (heart muscle cells), which enhances the heart’s contraction power.
Post-Infarction Recovery: It helps the heart recover after injury or significant stress, such as a myocardial infarction (heart attack).
Improved Pumping Efficiency: Studies suggest it improves ejection fraction, cardiac output, and overall exercise tolerance.
Reduction of Scar Tissue (Anti-Fibrotic)Fibroblast Regulation: Following cardiac injury, fibroblasts typically create excess scar tissue. Cardiogen modulates fibroblast activity to limit this overactivity.Preserving Architecture: By minimizing scar formation, it helps preserve more functional, elastic heart tissue and improves remodeling.
Cellular Protection and Anti-AgingApoptosis Suppression: It balances the cell death-survival equation by suppressing programmed cell death (apoptosis) in healthy myocardial cells, potentially by downregulating the p53 protein.
DNA and Mitochondrial Safeguards: It protects cell frameworks against oxidative stress and maintains mitochondrial energy efficiency, helping cells hold onto fuel under strain.
Reversing Cellular Decline: Research demonstrates a strong regenerative effect on both young and aged cardiac tissues, aiding longevity applications.
Broader Systemic ApplicationsAngiogenesis Support: It helps stimulate the growth of new blood vessels, enhancing microcirculation and blood supply to oxygen-deprived tissues.
Selective Tumor Apoptosis: Interestingly, while it protects healthy cells, early rodent models suggest it can selectively increase apoptosis and cause hemorrhagic necrosis in cancerous tumor cells (such as sarcoma).
Extracellular Matrix Synthesis: It influences non-cardiac fibroblasts to promote collagen and elastin production, aiding general tissue integrity.

BPC-157 is a synthetic peptide derived from stomach acid protein, heavily researched in animal models for its potential to accelerate tissue regeneration, promote new blood vessel growth, and reduce inflammation. It is touted for aiding muscle, tendon, and ligament repair, as well as protecting the gut lining.
Tissue & Joint Healing:
BPC-157 has been shown in rodent models to accelerate the repair of tendons, ligaments, and skeletal muscle by promoting collagen synthesis and cell migration.
Angiogenesis:
It appears to promote healing by stimulating the formation of new blood vessels (angiogenesis).
Gut Health:
Originally discovered in human gastric juice, it shows potential for protecting the stomach lining, healing gastric ulcers, and managing inflammatory bowel conditions in animals.
Anti-Inflammatory:
It helps modulate inflammatory pathways, which is believed to help alleviate swelling and pain associated with musculoskeletal injuries.

PURE VIP 10MG VIAL – R 1900
About VIP
VIP is a naturally occurring neuropeptide that plays crucial roles in immune regulation, gut health, inflammation control, and neuroprotection. It’s particularly valuable for research into mold illness, CIRS (Chronic Inflammatory Response Syndrome), and autoimmune conditions.
How It Works in Research
It works by modulating immune system responses, reducing inflammatory cytokines, improving gut barrier function, and protecting neurons from damage. It helps regulate the inflammatory cascade, supports healthy immune function, and promotes tissue repair throughout the body, particularly in the brain and gut.
Research Applications
Ideal for research into treating mold illness and CIRS, managing autoimmune conditions, reducing chronic inflammation, improving gut health and intestinal permeability, neuroprotection, and supporting recovery from inflammatory conditions.
Functional Performance Profile
Cognitive Function
Inflammation Reduction
Gut Health
Key Benefits
Immune System Support
Anti-Inflammatory Effects
Gut Health Enhancement
Product Specifications
Purity: 99.5%
Form: Lyophilized peptide
Storage: 2-9°C Refrigerated
Research Information
Type: Neuropeptide/hormone
Focus: Immune and inflammatory response
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water

SS-31 (also known as elamipretide or Bendavia) is a synthetic tetrapeptide that targets and repairs cell mitochondria. Its primary benefit is optimizing cellular energy production and reducing inner-membrane cell stress. By binding directly to a crucial inner mitochondrial fat molecule called cardiolipin, SS-31 protects cell structures and prevents systemic damage.
1. Boosted Cellular Energy Production
Optimized ATP synthesis: Mitochondria are the cell “powerhouses”. SS-31 stabilizes the inner mitochondrial membrane, ensuring maximum production of adenosine triphosphate (ATP), your body’s main unit of cellular energy.
Reversed fatigue: Studies highlight its capacity to reverse age-related energy deficits in muscle cells, helping alleviate chronic fatigue and metabolic sluggishness.
2. At-the-Source Antioxidant Defense
Reduced ROS production: Unlike traditional oral antioxidants that scavenge free radicals after damage occurs, SS-31 keeps the mitochondrial electron transport chain structurally aligned. This prevents the excessive leakage and formation of reactive oxygen species (ROS) in the first place.
Cellular survival: Minimizing mitochondrial oxidative stress shields cellular DNA from damage and blocks pathways that lead to premature cell death.
3. Cardioprotective Actions
Heart failure protection: SS-31 has shown a capacity to suppress pressure overload-induced cardiac hypertrophy (heart enlargement) and prevent tissue failure.
Arterial health: In preclinical trials, the peptide successfully inhibited the formation of foam cells, which are directly responsible for causing plaque build-up and atherosclerosis.
Ischemia recovery: It minimizes tissue damage when blood flow is blocked and subsequently restored (ischemia-reperfusion injury) to the heart muscle.
4. Neuroprotection & Cognitive Support
Brain injury mitigation: Research indicates SS-31 can cross the blood-brain barrier. It helps counter secondary brain injuries by reversing mitochondrial failure directly following a traumatic brain injury (TBI).
Reduced neuroinflammation: By maintaining the structural integrity of the inner cell membrane, it limits the chronic neuroinflammation linked to degenerative cognitive conditions like Alzheimer’s.
5. Enhanced Physical Endurance & Muscle Recovery
Fatigue resistance: Preclinical findings published in Innerbody Research and other medical literature note that treated skeletal muscles become significantly more resistant to fatigue.
Improved exercise tolerance: It enhances treadmill endurance and prevents muscle atrophy (wasting) due to physical inactivity or advanced age.
6. Kidney and Organ Protection
Glomerular protection: The kidneys require vast amounts of ATP to filter blood waste. SS-31 helps preserve kidney structural architecture, limits tissue scarring (glomerulosclerosis), and decreases tubular injury.
Metabolic stress buffer: It protects renal health from damage brought on by high-fat diets or diabetic conditions.

PURE THYMOSIN ALPHA-1 10MG VIAL –
R 1500
About Thymosin Alpha-1
Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from the thymus gland.
How It Works in Research
Researchers investigate Thymosin Alpha-1 for its potential ability to support T-cell maturation, immune signalling and cytokine activity.
Research Applications
Immune-function research Host-defence investigations Cellular-health studies Healthy-ageing research
Functional Performance Profile
Immune Function Research
Cellular Defence Research
Healthy Ageing Support
Key Benefits
Studied for immune-system support
Investigated for T-cell function
Researched for host-defence pathways
Investigated for cytokine signalling
Popular in immune-health research
Product Specifications
Product Name: Thymosin Alpha-1
Alternate Name: Tα1
Strength: 10mg
Research Information
Purity Standard: ≥99%
Appearance: Lyophilised Powder
Category: Immune Research Peptide
Included with your purchase
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

Kisspeptin is a foundational neuropeptide that acts as the primary “master switch” for human reproduction. It binds to receptors in the brain to trigger the release of Gonadotropin-Releasing Hormone (GnRH), which in turn stimulates the production of Luteinising Hormone (LH) and Follicle-Stimulating Hormone (FSH).
Unlike traditional hormone replacement therapies that suppress your body’s natural systems, kisspeptin therapy works upstream to optimize your endogenous hormone pathways.
Boosts Natural Testosterone: It prompts the pituitary gland to secrete LH, signaling the testes to increase natural testosterone production without causing testicular atrophy.
Enhances Libido and Sexual Desire: Clinical trials show it modulates brain networks tied to romantic and sexual attraction. It is actively researched as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in both men and women.
Improves Fertility Outcomes: By driving the pulsatile release of GnRH, it aids in regulating sperm production in men and controlling ovulation in women. It is also utilized in advanced IVF protocols to trigger egg maturation more safely than traditional triggers.
Restores Ovulatory and Menstrual Cycles: It helps treat reproductive disorders like hypothalamic amenorrhea (absent periods due to stress or low body weight) by restarting dormant hormonal cascades.
Protects Lean Muscle and Performance: By safely optimizing testosterone-to-estrogen ratios, users frequently note improved recovery, mood stability, and body composition.
Beyond reproductive health, scientific investigations indicate that kisspeptin receptors are distributed throughout other bodily tissues:
Metabolic Integration: Kisspeptin neurons interact with energy-sensing hormones like leptin and insulin, acting as a crucial link between metabolic health and reproductive function.
Oncology Foundations: Originally named “metastin,” early research highlighted the peptide’s natural ability to suppress the spread and metastasis of certain cancer types.
Skin Integrity: Recent dermatological laboratory models show that specific kisspeptin fragments may suppress UV-induced stress genes, helping to protect skin collagen and minimize signs of aging.

Tesamorelin is a synthetic peptide that mimics natural growth hormone-releasing hormone (GHRH) to trigger the body’s own release of growth hormone. Its most prominent and clinically proven benefit is a significant reduction in visceral adipose tissue (VAT), the deep abdominal fat that wraps around internal organs.
Unlike general weight loss drugs or direct human growth hormone (HGH) injections, tesamorelin preserves natural hormonal rhythms while selectively breaking down dangerous belly fat.
Primary Physical and Metabolic Benefits
Targeted Visceral Fat Loss: It reduces deep abdominal fat by approximately 15% to 18% over a six-month period. It achieves this by activating lipolysis (fat breakdown) specifically in the visceral compartment while leaving subcutaneous fat relatively untouched.
Muscle Preservation and Density: While reducing fat, it increases skeletal muscle area and truncal muscle density. This protects lean tissue from wasting during fat loss phases, aiding in overall body recomposition.
Improved Lipid Profiles: It helps lower elevated triglycerides and optimize overall cholesterol markers, which are critical metrics for cardiovascular health.
Reduction in Liver Fat: Clinical evidence shows tesamorelin can reduce hepatic (liver) fat by up to 37%. This makes it a highly promising option for individuals dealing with nonalcoholic fatty liver disease (NAFLD).
Secondary Wellness Benefits
Enhanced Sleep Quality: By synchronizing with natural nighttime growth hormone pulses, many users report deeper, more restorative slow-wave sleep cycles.
Accelerated Recovery: Higher levels of natural growth hormone support cellular repair, collagen turnover, and faster healing from heavy physical exertion or joint strain.
Potential Cognitive Support: Because growth hormone stimulates the production of insulin-like growth factor-1 (IGF-1), it is linked to cognitive improvements, including sharper focus and better verbal memory in older adults.
Clinical Context and Approvals
Tesamorelin is FDA-approved (sold under the brand name Egrifta) specifically for reducing excess abdominal fat in HIV patients experiencing lipodystrophy. While it is widely prescribed off-label in wellness and anti-aging clinics for general abdominal fat management, it is critical to note that it is not a total weight-loss drug and will not significantly change overall body weight or suppress appetite like GLP-1 medications. Additionally, it is strictly prohibited by the World Anti-Doping Agency (WADA) for competitive athletes.